_id
6915e8cabc934aba376b1b9b
Ticker
PTIXW
Name
Protagenic Therapeutics Inc
Exchange
NASDAQ
Address
701 Anacapa Street, Santa Barbara, CA, United States, 93101
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://phytanix.com
Description
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Last Close
0.0188
Volume
22995
Current Price
0.01
Change
-0.0089
Last Updated
2026-01-06T09:42:09.756Z
Image
-
Ipo Date
2021-04-27T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1113864
Operating Income
-1113864
Interest Expense
34337
Pretax Income
-869496
Net Income
-869496
Eps
-0.47015311543434074
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-1113864
Operating Margin
-
Total Other Income Expense Net
244368
Cash
2722451
Short Term Investments
-
Receivables
-
Inventories
1075
Total Current Assets
2858212
Property Plant Equipment
51407
Total Assets
2144635
Payables
1641443
Short Term Debt
3156052
Long Term Debt
-
Total Liabilities
9703412
Equity
-7558777
Bs_currency_symbol
USD
Depreciation
230781
Change In Working Capital
-123402
Cash From Operations
-1494649
Capital Expenditures
0
Cash From Investing
943180
Cash From Financing
4305034
Net Change In Cash
1849491
Cf_currency_symbol
USD
PE
-
PB
-0.0024466775511435253
ROE
11.503130731333918
ROA
-40.54284295462865
FCF
-1494649
Fcf Percent
-
Piotroski FScore
0
Health Score
31
Deep Value Investing Score
0
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1113864
Quarters > 0 > income Statement > operating Income
-1113864
Quarters > 0 > income Statement > interest Expense
34337
Quarters > 0 > income Statement > pretax Income
-869496
Quarters > 0 > income Statement > net Income
-869496
Quarters > 0 > income Statement > eps
-0.47015311543434074
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1849389
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1113864
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
244368
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2722451
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
1075
Quarters > 0 > balance Sheet > total Current Assets
2858212
Quarters > 0 > balance Sheet > property Plant Equipment
51407
Quarters > 0 > balance Sheet > total Assets
2144635
Quarters > 0 > balance Sheet > payables
1641443
Quarters > 0 > balance Sheet > short Term Debt
3156052
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9703412
Quarters > 0 > balance Sheet > equity
-7558777
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-4487014
Quarters > 0 > cash Flow > depreciation
230781
Quarters > 0 > cash Flow > change In Working Capital
-123402
Quarters > 0 > cash Flow > cash From Operations
-1494649
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
943180
Quarters > 0 > cash Flow > cash From Financing
4305034
Quarters > 0 > cash Flow > net Change In Cash
1849491
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.47015311543434074
Quarters > 0 > ratios > PB
-0.0024466775511435253
Quarters > 0 > ratios > ROE
11.503130731333918
Quarters > 0 > ratios > ROA
-40.54284295462865
Quarters > 0 > ratios > FCF
-1494649
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
12571
Quarters > 1 > income Statement > gross Profit
-12571
Quarters > 1 > income Statement > operating Expenses
2331843
Quarters > 1 > income Statement > operating Income
-2344412
Quarters > 1 > income Statement > interest Expense
238727
Quarters > 1 > income Statement > pretax Income
-5057523
Quarters > 1 > income Statement > net Income
-5057523
Quarters > 1 > income Statement > eps
-1.3664453345999408
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3701226
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4806225
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-2713111
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
4096189
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
98632
Quarters > 1 > balance Sheet > inventories
1095
Quarters > 1 > balance Sheet > total Current Assets
4330993
Quarters > 1 > balance Sheet > property Plant Equipment
63979
Quarters > 1 > balance Sheet > total Assets
6488200
Quarters > 1 > balance Sheet > payables
2083633
Quarters > 1 > balance Sheet > short Term Debt
4013009
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10462212
Quarters > 1 > balance Sheet > equity
-3974012
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5057523
Quarters > 1 > cash Flow > depreciation
12571
Quarters > 1 > cash Flow > change In Working Capital
448333
Quarters > 1 > cash Flow > cash From Operations
-1167263
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
943180
Quarters > 1 > cash Flow > cash From Financing
4422960
Quarters > 1 > cash Flow > net Change In Cash
4081658
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.3664453345999408
Quarters > 1 > ratios > PB
-0.009313575298715756
Quarters > 1 > ratios > ROE
127.26491515375393
Quarters > 1 > ratios > ROA
-77.9495545759995
Quarters > 1 > ratios > FCF
-1167266
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
12572
Quarters > 2 > income Statement > gross Profit
-12572
Quarters > 2 > income Statement > operating Expenses
1448000
Quarters > 2 > income Statement > operating Income
-1448000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1440000
Quarters > 2 > income Statement > net Income
-1440000
Quarters > 2 > income Statement > eps
-2.752372487743341
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
523185
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1436000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
8103
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
872960
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
928176
Quarters > 2 > balance Sheet > property Plant Equipment
60474
Quarters > 2 > balance Sheet > total Assets
988650
Quarters > 2 > balance Sheet > payables
165247
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1076979
Quarters > 2 > balance Sheet > equity
-88329
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1440005
Quarters > 2 > cash Flow > depreciation
12572
Quarters > 2 > cash Flow > change In Working Capital
123402
Quarters > 2 > cash Flow > cash From Operations
-1068017
Quarters > 2 > cash Flow > capital Expenditures
3
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
102519
Quarters > 2 > cash Flow > net Change In Cash
-965509
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.752372487743341
Quarters > 2 > ratios > PB
-0.05923139625717488
Quarters > 2 > ratios > ROE
1630.2686546887205
Quarters > 2 > ratios > ROA
-145.6531634046427
Quarters > 2 > ratios > FCF
-1068020
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-25143
Quarters > 3 > income Statement > cost Of Revenue
25143
Quarters > 3 > income Statement > gross Profit
-50286
Quarters > 3 > income Statement > operating Expenses
1643000
Quarters > 3 > income Statement > operating Income
-1643000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-1554000
Quarters > 3 > income Statement > net Income
-1554000
Quarters > 3 > income Statement > eps
-0.23907107503062616
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6500159
Quarters > 3 > income Statement > income Tax Expense
2
Quarters > 3 > income Statement > EBITDA
-1541000
Quarters > 3 > income Statement > operating Margin
6534.621962375213
Quarters > 3 > income Statement > total Other Income Expense Net
89435
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1838469
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1882867
Quarters > 3 > balance Sheet > property Plant Equipment
73046
Quarters > 3 > balance Sheet > total Assets
1955913
Quarters > 3 > balance Sheet > payables
102962
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
942759
Quarters > 3 > balance Sheet > equity
1013154
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1553743
Quarters > 3 > cash Flow > depreciation
12571
Quarters > 3 > cash Flow > change In Working Capital
556354
Quarters > 3 > cash Flow > cash From Operations
-819791
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1602056
Quarters > 3 > cash Flow > net Change In Cash
782664
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.23907107503062616
Quarters > 3 > ratios > PB
0.06415766013853767
Quarters > 3 > ratios > ROE
-153.38240780769755
Quarters > 3 > ratios > ROA
-79.45138664143036
Quarters > 3 > ratios > FCF
-819791
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
32.60513860716701
Quarters > 3 > health Score
48
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
50286
Annuals > 0 > income Statement > gross Profit
-50286
Annuals > 0 > income Statement > operating Expenses
5701000
Annuals > 0 > income Statement > operating Income
-5701000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-5525000
Annuals > 0 > income Statement > net Income
-5525000
Annuals > 0 > income Statement > eps
-1.1275510204081634
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4900000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-5475000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
175606
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1838469
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1882867
Annuals > 0 > balance Sheet > property Plant Equipment
73046
Annuals > 0 > balance Sheet > total Assets
1955913
Annuals > 0 > balance Sheet > payables
102962
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
942759
Annuals > 0 > balance Sheet > equity
1013154
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-5525344
Annuals > 0 > cash Flow > depreciation
50286
Annuals > 0 > cash Flow > change In Working Capital
467543
Annuals > 0 > cash Flow > cash From Operations
-4216517
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
2802880
Annuals > 0 > cash Flow > cash From Financing
1963546
Annuals > 0 > cash Flow > net Change In Cash
550576
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.1275510204081634
Annuals > 0 > ratios > PB
0.07254573342255964
Annuals > 0 > ratios > ROE
-545.3267716457715
Annuals > 0 > ratios > ROA
-282.4767768300533
Annuals > 0 > ratios > FCF
-4216517
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
28218
Annuals > 1 > income Statement > gross Profit
-28218
Annuals > 1 > income Statement > operating Expenses
4499000
Annuals > 1 > income Statement > operating Income
-4527000
Annuals > 1 > income Statement > interest Expense
107682
Annuals > 1 > income Statement > pretax Income
-5000000
Annuals > 1 > income Statement > net Income
-5000000
Annuals > 1 > income Statement > eps
-1.1507479861910241
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4345000
Annuals > 1 > income Statement > income Tax Expense
2
Annuals > 1 > income Statement > EBITDA
-4499000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-474000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1287893
Annuals > 1 > balance Sheet > short Term Investments
2768119
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
4200037
Annuals > 1 > balance Sheet > property Plant Equipment
123332
Annuals > 1 > balance Sheet > total Assets
4323369
Annuals > 1 > balance Sheet > payables
113802
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
655252
Annuals > 1 > balance Sheet > equity
3668117
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5000497
Annuals > 1 > cash Flow > depreciation
28218
Annuals > 1 > cash Flow > change In Working Capital
-114412
Annuals > 1 > cash Flow > cash From Operations
-3703776
Annuals > 1 > cash Flow > capital Expenditures
149775
Annuals > 1 > cash Flow > cash From Investing
4775482
Annuals > 1 > cash Flow > cash From Financing
0
Annuals > 1 > cash Flow > net Change In Cash
1072704
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.1507479861910241
Annuals > 1 > ratios > PB
0.017767971959454947
Annuals > 1 > ratios > ROE
-136.3097196736091
Annuals > 1 > ratios > ROA
-115.6505493748047
Annuals > 1 > ratios > FCF
-3853551
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
30
Annuals > 2 > income Statement > gross Profit
-30
Annuals > 2 > income Statement > operating Expenses
3558000
Annuals > 2 > income Statement > operating Income
-3558000
Annuals > 2 > income Statement > interest Expense
137456
Annuals > 2 > income Statement > pretax Income
-3556000
Annuals > 2 > income Statement > net Income
-3556000
Annuals > 2 > income Statement > eps
-0.8235294117647058
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4318000
Annuals > 2 > income Statement > income Tax Expense
46051
Annuals > 2 > income Statement > EBITDA
-3418018
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2283
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
215189
Annuals > 2 > balance Sheet > short Term Investments
7763517
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
8035645
Annuals > 2 > balance Sheet > property Plant Equipment
1775
Annuals > 2 > balance Sheet > total Assets
8037420
Annuals > 2 > balance Sheet > payables
155486
Annuals > 2 > balance Sheet > short Term Debt
344230
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1119862
Annuals > 2 > balance Sheet > equity
6917558
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3555505
Annuals > 2 > cash Flow > depreciation
30
Annuals > 2 > cash Flow > change In Working Capital
540132
Annuals > 2 > cash Flow > cash From Operations
-1993814
Annuals > 2 > cash Flow > capital Expenditures
1805
Annuals > 2 > cash Flow > cash From Investing
1596974
Annuals > 2 > cash Flow > cash From Financing
0
Annuals > 2 > cash Flow > net Change In Cash
-325982
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.8235294117647058
Annuals > 2 > ratios > PB
0.009363130746428146
Annuals > 2 > ratios > ROE
-51.405423705880025
Annuals > 2 > ratios > ROA
-44.24305311903571
Annuals > 2 > ratios > FCF
-1995619
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
4140000
Annuals > 3 > income Statement > operating Income
-4140000
Annuals > 3 > income Statement > interest Expense
496912
Annuals > 3 > income Statement > pretax Income
-4523000
Annuals > 3 > income Statement > net Income
-4523000
Annuals > 3 > income Statement > eps
-1.2274084124830393
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3685000
Annuals > 3 > income Statement > income Tax Expense
463705
Annuals > 3 > income Statement > EBITDA
-4139714
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-383000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
541171
Annuals > 3 > balance Sheet > short Term Investments
9830085
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
11059923
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
11059923
Annuals > 3 > balance Sheet > payables
278957
Annuals > 3 > balance Sheet > short Term Debt
186149
Annuals > 3 > balance Sheet > long Term Debt
318433
Annuals > 3 > balance Sheet > total Liabilities
1117968
Annuals > 3 > balance Sheet > equity
9941955
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4522934
Annuals > 3 > cash Flow > depreciation
427137
Annuals > 3 > cash Flow > change In Working Capital
-140389
Annuals > 3 > cash Flow > cash From Operations
-2798614
Annuals > 3 > cash Flow > capital Expenditures
4
Annuals > 3 > cash Flow > cash From Investing
-9909601
Annuals > 3 > cash Flow > cash From Financing
12577664
Annuals > 3 > cash Flow > net Change In Cash
-129920
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.2274084124830393
Annuals > 3 > ratios > PB
0.005559771694802481
Annuals > 3 > ratios > ROE
-45.494070331237666
Annuals > 3 > ratios > ROA
-40.89540225551299
Annuals > 3 > ratios > FCF
-2798618
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.47015311543434074
Valuation > metrics > PB
-0.0024466775511435253
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
11.503130731333918
Profitability > metrics > ROA
-30.4209764706047
Profitability > final Score
38
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-32.43917639863704
Risk > final Score
-100
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5957717517162603
Liquidity > metrics > Quick Ratio
0.595547676443644
Liquidity > final Score
40
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
30
Prev Risks > 0
-9
Prev Risks > 1
-1418
Prev Risks > 2
-458
Prev Liquidities > 0
46
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:26:17.903Z
Earnings History > 0 > period
2021-06-30
Earnings History > 0 > report Date
2021-09-30
Earnings History > 0 > date
2021-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0532
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.0532
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.1068
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.1068
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.1147
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.1147
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0497
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0497
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1018
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.1018
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0553
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0553
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0486
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0486
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0731
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0731
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.012
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.012
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0271
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0271
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0584
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0584
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.077
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.077
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0485
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0485
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0654
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0654
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0583
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0583
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0678
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0678
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0443
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0443
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.044
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.044
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0641
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0641
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0571
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0571
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0572
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0572
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0793
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0793
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-52.8607
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-52.8607
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0661
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0661
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0665
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0665
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0165
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0165
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-09-30
Earnings History > 26 > report Date
2014-12-31
Earnings History > 26 > date
2014-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0088
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0088
Earnings History > 26 > surprise Percent
-
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhat is the target price for Exelon Corporation stock - Market Weekly Review & Free Risk Controlled Daily Trade Plans baoquankhu1.vn
Read more →Pharma News: Can Harrow Inc. be recession proof - Trade Risk Assessment & Weekly High Return Stock Forecasts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Protagenic Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-06-30
EPS Actual
-0.0532
EPS Estimate
0
EPS Difference
-0.0532
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.